Osaic Holdings’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$624 Hold
175
﹤0.01% 7600
2026
Q1
$521 Sell
175
-1,450
-89% -$5.79K ﹤0.01% 7425
2025
Q4
$7.93K Buy
1,625
+1,450
+829% +$7.41K ﹤0.01% 6460
2025
Q3
$827 Hold
175
﹤0.01% 7422
2025
Q2
$715 Buy
+175
New +$467 ﹤0.01% 7266
2023
Q3
Sell
-5
Closed -$8 7485
2023
Q2
$8 Hold
5
﹤0.01% 7412
2023
Q1
$5 Sell
5
-4,569
-100% -$5.26K ﹤0.01% 7468
2022
Q4
$5K Hold
4,574
﹤0.01% 6291
2022
Q3
$4K Hold
4,574
﹤0.01% 6498
2022
Q2
$7K Sell
4,574
-4,100
-47% -$11.1K ﹤0.01% 6313
2022
Q1
$38K Buy
8,674
+4,100
+90% +$19.5K ﹤0.01% 5285
2021
Q4
$27K Hold
4,574
﹤0.01% 5588
2021
Q3
$40K Hold
4,574
﹤0.01% 5271
2021
Q2
$46K Buy
4,574
+4,569
+91,380% +$38.1K ﹤0.01% 5107
2021
Q1
$0 Hold
5
﹤0.01% 6899
2020
Q4
$0 Hold
5
﹤0.01% 6517
2020
Q3
$0 Sell
5
-200
-98% -$1.46K ﹤0.01% 6340
2020
Q2
$2K Sell
205
-200
-49% -$1.58K ﹤0.01% 5809
2020
Q1
$2K Buy
+405
New +$3.44K ﹤0.01% 5703

Other funds holding NEPH

Osaic Holdings's NEPH Position: Q2 2026 in Review

Osaic Holdings held its Nephros (NEPH) position steady in Q2 2026 at 175 shares worth $624. The position accounts for ﹤0.01% of the portfolio, ranked #7600.

Osaic Holdings first reported a position in NEPH in Q1 2020 and has held it in 19 quarters since. The position peaked at $46K in Q2 2021. 29 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Osaic Holdings held 175 shares of Nephros worth $624 as of Q2 2026.
  • Osaic Holdings left its Nephros share count unchanged in Q2 2026.
  • Nephros made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7600 holding.
  • Osaic Holdings first reported a position in Nephros in Q1 2020 and has held it in 19 quarters since.
  • Osaic Holdings's Nephros position peaked at $46K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.